Patents for A61P 17 - Drugs for dermatological disorders (106,455)
04/2000
04/12/2000EP0991412A1 Aminoacyl sulfamides for the treatment of hyperproliferative disorders
04/12/2000EP0991406A1 Il-8 receptor antagonists
04/12/2000EP0862440A4 Therapeutic use of hemoglobin in promoting wound healing
04/12/2000EP0707566B1 Novel structural analogues of vitamin d
04/12/2000CN1249944A Effective chilblain treating liquid
04/12/2000CN1249935A Preparation of collagenous fiber tissue for animal's organs and blood vessels
04/12/2000CN1249931A Local medicine composition for healing wound
04/12/2000CN1051316C Cortinoid derivative, its producing process and medicine containing the same
04/12/2000CN1051241C Liniment for chilblain
04/12/2000CN1051231C Traditional Chinese medicine plaster for curing dermatosis and its preparing technology
04/12/2000CN1051228C Novel medical composition containing hyaluronic acid associates and its preparing process
04/12/2000CN1051227C Application in preparation of fluorinated vitamin D3 derivative
04/11/2000US6048880 Therapy for cytokine sensitive diseases
04/11/2000US6048873 Skin disorders
04/11/2000US6048869 Reductase inhibitors
04/11/2000US6048860 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
04/11/2000US6048855 Topical composition containing capsazepine
04/11/2000US6048844 Treatment of conditions and disease
04/11/2000US6048549 Powder compositions
04/11/2000CA1340955C Stilbene derivatives
04/08/2000CA2285120A1 Heterocycles
04/06/2000WO2000018919A1 Human kinesin-like motor protein
04/06/2000WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000WO2000018760A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders
04/06/2000WO2000018759A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
04/06/2000WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors
04/06/2000WO2000018735A1 2-substituted heterocyclic sulfonamides
04/06/2000WO2000018733A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
04/06/2000WO2000018725A1 2-substituted ketoamides
04/06/2000WO2000018437A1 Tie2 antagonist antibodies
04/06/2000WO2000018428A2 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor
04/06/2000WO2000018424A1 Use of substances with oxytocin activity in order to create cell regeneration
04/06/2000WO2000018361A2 Method of treating hair loss using sulfonamides
04/06/2000WO2000018358A2 Method of treating hair loss using ketoamides
04/06/2000WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor
04/06/2000WO2000018230A1 Combination of bisphosphonate and tetracycline
04/06/2000WO2000018212A2 Platelet-derived growth factor c, dna coding therefor, and uses thereof
04/06/2000WO2000006588B1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
04/06/2000WO1999011237A9 Dermatological compositions
04/06/2000DE19845202A1 Haarwuchsmittel Hair restorer
04/06/2000CA2345641A1 A method for treating inflammatory diseases by administering a thrombin inhibitor
04/06/2000CA2344658A1 Human kinesin-like motor protein
04/06/2000CA2344561A1 Platelet-derived growth factor c, dna coding therefor, and uses thereof
04/06/2000CA2343934A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000CA2343335A1 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor
04/06/2000CA2343098A1 Combination of bisphosphonate and tetracycline
04/06/2000CA2340454A1 Benzamide derivatives and their use as cytokine derivatives
04/06/2000CA2338442A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
04/05/2000EP0990000A1 Connective tissue growth factor-3
04/05/2000EP0989993A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue
04/05/2000EP0989987A1 Spiro-azacyclic derivatives and their use as therapeutic agents
04/05/2000EP0989985A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
04/05/2000EP0989853A1 Self-regulated apoptosis of inflammatory cells by gene therapy
04/05/2000EP0989845A1 Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
04/05/2000EP0766664B1 Metalloproteinase inhibitors
04/05/2000EP0734371B1 Novel retinoid conjugate compounds and methods for treating skin aging
04/05/2000EP0618811B1 Proteolytic mixture containing escharase and method of isolating same
04/05/2000CN1249749A Phthalazinones
04/05/2000CN1249748A Small molecules useful in treatment of inflamatory disease
04/05/2000CN1249743A Arylsulfonylamino hydroxamic acid derivs
04/05/2000CN1249742A Anti-inflammatory compounds
04/05/2000CN1249688A Self-regulated apoptosis of inflammatory cells by gene therapy
04/05/2000CN1249677A Composition for external use
04/05/2000CN1249177A Activator administration system contg. composition based on salicylic deriv. in film structure, and its use
04/05/2000CN1249175A Skin-protecting cosmetics
04/05/2000CN1249170A Wrinkle-proof composition contg. synthetic and/or natural tightening polymer and dendritic polyester mixture
04/05/2000CN1051003C Chinese patent medicine for treating burn and scald
04/04/2000US6046340 Imidazole containing pseudodipeptide product and compositions containing the same
04/04/2000US6046238 Method for treating or preventing the spread of acne vulgaris
04/04/2000US6046220 Propynyl or dienyl biaromatic compounds
04/04/2000US6046219 Administering to the patient for treating the conditions mediated by collagen formation together with cell proliferation a hydroxypyridine derivative
04/04/2000US6046204 Treatment of immunosuppressive, autoimmune, inflammatory, proliferative and hyperproliferative diseases including cancer, and of cutaneous manifestations of immunologically mediated diseases, for example rheumatoid arthritis, lupus
04/04/2000US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
04/04/2000US6046170 Therapeutic use of hemoglobin to treat head injury
04/04/2000US6045785 Comprising a sterol sulfate, aluminum chlorohydrate, and an esterase inhibitor, a bactericidal agent, or a bacteriostatic agent
04/01/2000CA2284387A1 Use of peptide preventing skin intolerance reactions, notably in cosmetic compounds
03/2000
03/30/2000WO2000017371A1 Polynucleotide constructs and uses thereof
03/30/2000WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000WO2000017354A1 Human isre-binding protein
03/30/2000WO2000017232A2 Regulatory protein from human keratinocytes
03/30/2000WO2000017222A1 31 human secreted proteins
03/30/2000WO2000017204A1 INHIBITORS OF p38
03/30/2000WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000WO2000017195A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/30/2000WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/30/2000WO2000017159A1 Arylsulfonanilide ureas
03/30/2000WO2000017143A1 Derivatives of phenantrene for medicinal use and a process for their preparation
03/30/2000WO2000017133A2 Lta4 hydrolase inhibitors
03/30/2000WO2000016809A1 ANTISENSE MODULATION OF RhoB EXPRESSION
03/30/2000WO2000016791A1 Myrtle extract, preparation method and use
03/30/2000WO2000016789A1 Method for removing undesirable toxic alkaloids from plants or vegetable preparations
03/30/2000WO2000016781A1 Chk1 kinase inhibitors
03/30/2000WO2000016775A1 Topical formulation of alkyl-, phenyl-pyridone
03/30/2000WO2000016772A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
03/30/2000WO2000016769A1 ACTIVE ENANTIOMER OF RARη-SPECIFIC AGONIST
03/30/2000WO2000016739A1 Use of at least a10-hydroxy-2- decenoic acid derivative in a composition for promoting skin scaling